FDA Adverse Event
Injury
Summary report: N
ENDURANT
MDR report key: 4221678
·
Received November 3, 2014
Report
- Report Number
- 2953200-2014-02286
- Event Type
- Injury
- Date Received
- November 3, 2014
- Date of Event
- October 6, 2014
- Report Date
- October 7, 2014
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- MIH
- PMA / PMN Number
- P100021
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
(B)(4)
Description of Event or Problem · 1
AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM. ANEURYSM AND VESSEL MORPHOLOGY WAS NOT REPORTED. IT WAS REPORTED THAT A CT REVEALED THAT THE PATIENT¿S ANEURYSM WAS ENLARGED DUE TO A TYPE IA AND A TYPE IB ENDOLEAK. THE PHYSICIAN PERFORMED AN INTERVENTION WHERE EMBOLIZATION WAS INTENTIONALLY CARRIED OUT PUTTING MICRO COIL AND N-BUTYL CYANOACRYLATE (NBCA) IN THE ANEURYSM TO RESOLVE THE TYPE IA ENDOLEAK. AS FOR TYPE IB ENDOLEAK, AN ADDITIONAL LIMB 16X13X93 WAS ADDED IN THE EXTERNAL ILIAC ARTERY (EIA) LANDING AFTER EMBOLIZATION OF LEFT INTERNAL ILIAC ARTERY (IIA). NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS DOING FINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 702385 | ENDURANT | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | MEDTRONIC IRELAND | V01125021 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00085 YR | Required Intervention |